The use of engineered ketoreductases (KREDS), both as whole microbial cells and isolated enzymes, in the highly enantiospecific reduction of prochiral ketones is reviewed. The homochiral alcohol products are key intermediates in, for example, pharmaceuticals synthesis. The application of sophisticated protein engineering and enzyme immobilisation techniques to increase industrial viability are discussed.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1039/d3cc01474f | DOI Listing |
Publication Analysis
Top Keywords
engineering ketoreductases
4
ketoreductases enantioselective
4
enantioselective synthesis
4
synthesis chiral
4
chiral alcohols
4
alcohols engineered
4
engineered ketoreductases
4
ketoreductases kreds
4
kreds microbial
4
microbial cells
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!